Designing Ultra-Short Antimicrobial Peptides From Lactoferricin: Potent 5-Amino-Acid Antibiotics
Five ultra-short (5-amino-acid) peptides designed from bovine lactoferricin's principles of hydrophobicity and charge showed potent antibacterial activity, demonstrating that effective antibiotics can be incredibly small.
Quick Facts
What This Study Found
Five synthetic 5-amino-acid peptides designed from lactoferricin's principles of lipophilic bulk and cationic charge showed potent broad-spectrum antibacterial activity, demonstrating ultra-short peptide antibiotics are viable.
Key Numbers
How They Did This
In-vitro antimicrobial study. Five 5-amino-acid peptides designed from lactoferricin structure-activity principles. Tested against panels of gram-positive and gram-negative bacteria by MIC determination.
Why This Research Matters
Shorter peptides are cheaper to make, more stable, and easier to formulate. Ultra-short antimicrobial peptides could be the most practical peptide antibiotics for clinical development.
The Bigger Picture
The minimum antibiotic size is smaller than assumed. Five amino acids with the right properties can kill bacteria, opening the door to peptide antibiotics as simple as small molecule drugs.
What This Study Doesn't Tell Us
In-vitro activity only. Ultra-short peptides may have different pharmacokinetics and toxicity profiles than longer antimicrobial peptides. Hemolytic activity needs assessment.
Questions This Raises
- ?Are 5-amino-acid peptides stable enough for clinical use?
- ?Do they retain selectivity for bacteria over human cells?
- ?Could they be produced as cheaply as conventional small-molecule antibiotics?
Trust & Context
- Key Stat:
- Just 5 amino acids Potent antibacterial activity from peptides of only 5 amino acids — simpler and cheaper than traditional 20-40 amino acid antimicrobial peptides
- Evidence Grade:
- Preliminary in-vitro evidence with broad-spectrum MIC data for rationally designed ultra-short peptides.
- Study Age:
- Published in 2003. Ultra-short antimicrobial peptides have become a significant area of drug development.
- Original Title:
- Antibacterial activity of short hydrophobic and basic-rich peptides.
- Published In:
- American journal of veterinary research, 64(9), 1088-92 (2003)
- Authors:
- Chen, Po-Wen, Shyu, Ching-Ling, Mao, Frank C
- Database ID:
- RPEP-00805
Evidence Hierarchy
Frequently Asked Questions
Can such tiny peptides really kill bacteria?
Yes — this study proves that just 5 amino acids with the right combination of hydrophobicity and charge can potently kill bacteria. The active ingredients of antimicrobial defense can be incredibly compact.
Why is smaller better?
Smaller peptides are dramatically cheaper to produce, more stable in storage and use, and easier to formulate into drugs. If 5 amino acids work as well as 30, the practical advantages are enormous.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00805APA
Chen, Po-Wen; Shyu, Ching-Ling; Mao, Frank C. (2003). Antibacterial activity of short hydrophobic and basic-rich peptides.. American journal of veterinary research, 64(9), 1088-92.
MLA
Chen, Po-Wen, et al. "Antibacterial activity of short hydrophobic and basic-rich peptides.." American journal of veterinary research, 2003.
RethinkPeptides
RethinkPeptides Research Database. "Antibacterial activity of short hydrophobic and basic-rich p..." RPEP-00805. Retrieved from https://rethinkpeptides.com/research/chen-2003-antibacterial-activity-of-short
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.